NICE is considering whether the recommendation wording of treatment being started in a tertiary epilepsy service for TA753 Cenobamate for focal onset seizures in epilepsy should be updated. Stakeholders in the original appraisal, or parties who have contacted NICE to enquire about an update, have been invited to comment on the review proposal.
Following the consultation, NICE will determine whether an update to the recommendation is needed and update stakeholders.
This page was last updated: